Loading...
Bienvenue sur la collection HAL du laboratoire de BECCOH
Quelques conseils pour une publication "idéHALe"
• Pensez à respecter la signature institutionnelle
Université Paris-Saclay, UVSQ, BECCOH, 92104, Boulogne-Billancourt, France..
• Participez à l'accès ouvert
N'attendez pas : dès que votre article est en ligne, déposez dans Hal sa version acceptée pour publication et indiquez un embargo de 6 mois.
La loi pour une république numérique vous autorise en effet à partager cette version 6 mois après publications, quelque-soit l'éditeur
Plus d'informations Archives Ouverte : quid de mes droits d'auteurs ?
• Vous souhaitez disposer d'une page web référençant toutes vos publications ?
Créez vous en 5 minutes un idHal et un CVHAL
N'hésitez pas à nous contacter pour toutes questions,
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
nous serions ravis d'échanger avec vous hal.bib@uvsq.fr
Dernières Publications en accès ouvert dans Hal
-
Paul Takam Kamga, Marie Mayenga, Louise Sebane, Adrien Costantini, Catherine Julie, et al.. Colony stimulating factor-1 (CSF-1) signalling is predictive of response to immune checkpoint inhibitors in advanced non-small cell lung cancer. Lung Cancer, 2024, 188, pp.107447. ⟨10.1016/j.lungcan.2023.107447⟩. ⟨hal-04517531⟩
-
Julie Lecuelle, Caroline Truntzer, Debora Basile, Luigi Laghi, Luana Greco, et al.. Machine learning evaluation of immune infiltrate through digital tumour score allows prediction of survival outcome in a pooled analysis of three international stage III colon cancer cohorts. EBioMedicine, 2024, 105, pp.105207. ⟨10.1016/j.ebiom.2024.105207⟩. ⟨hal-04626841⟩
-
Alexandra Kachaner, Raphaèle Seror, Fleur Cohen Aubart, Julien Henry, Thierry Lazure, et al.. Complete remission after a single bisphosphonate infusion in isolated bone Langerhans cell histiocytosis lesion: a case report and a narrative review of the literature. JBMR Plus, 2024, 8 (5), pp.ziae043. ⟨10.1093/jbmrpl/ziae043⟩. ⟨hal-04626829⟩
-
Robin Zagala, Nicolas Meyer, Philippe Saiag, Nora Kramkimel, Celeste Lebbe, et al.. Radiotherapy and prognostic factors in adnexal carcinomas: A retrospective study of 657 patients from the French CARADERM network. Journal of the European Academy of Dermatology and Venereology, In press, ⟨10.1111/jdv.20155⟩. ⟨hal-04626767⟩
-
Johanne Seguin, Mostafa El Hajjam, Josette Legagneux, Sarah Diakhaby, Nathalie Mignet, et al.. Radiofrequency Combined with Intratumoral Immunotherapy: Preclinical Results and Safety in Metastatic Colorectal Carcinoma. Pharmaceutics, 2024, 16 (3), pp.315. ⟨10.3390/pharmaceutics16030315⟩. ⟨hal-04626840⟩
Mots clés
Colorectal cancer
Biomarker
Wnt
Circulating cell-free DNA
Polyomavirus
Cutaneous squamous cell carcinoma
Metastatic
BRAF V600E
Mesenchymal stromal cells
Diagnosis
Immune checkpoint inhibitor
Colon cancer
Acute generalized exanthematous pustulosis
Cancer bronchique non à petites cellules
Abscopal effect anti-PD-1 antibody melanoma nivolumab pembrolizumab radiotherapy
Radiotherapy
Adjuvant
Follow-up
Dabrafenib
Immunomodulation
Chemoresistance
Lung cancer
Systemic therapy
Crizotinib
Resistance
Abscopal effect
TNM classification
Liver metastases
Melanoma
Prevention
Cancer
Anti-Tumor pharmacology
Colorectal carcinoma
Targeted therapy
Gastric bypass
Assisted reproductive techniques
Adverse events
EGFR
Androgen insensitivity
Immunohistochemistry
Invasive cutaneous squamous cell carcinoma
Osimertinib
Anti-PD-1 antibody
AZD9291
Thrombosis
Adjuvant therapy
Safety
COVID-19
Lung adenocarcinoma
ALK rearrangement
Trametinib
HIV
Cemiplimab
Anti-PD-1
BRAFV600E mutation
Anti-CTLA-4
Chemotherapy
Survival
Allelic imbalance
Children
Biomarkers
Adjuvant FOLFOX
BRAF
Prognosis
Radiofrequency ablation
Plasma
Immunotherapy
Molecular targeted therapies
ACTH
ADN tumoral circulant
Anti-PD1 blockade
Adapted physical activity molecular diagnosis oligometastatic disease pancreatic adenocarcinoma KRAS mutation
Prognostic
BRAF V600-mutation
Abdominal pain
Treatment
Histiocytosis
Toxicity
Langerhans cell histiocytosis
Advanced melanoma
Non-small cell lung cancer
Antibody-drug conjugate
Circulating tumor DNA
Anti-CTLA-4 anti-PD-1 elderly immune checkpoint inhibitors melanoma nonagenarian octogenarian
Nivolumab
Anti-PD1
AML
Surgical excision
Advanced
Metastatic cSCC
Staging
Merkel cell carcinoma
Antineoplastic agents
Locally advanced
Sonic Hedgehog
Immunothérapie
ADAMTS13
2-chlorodeoxyadenosine
Oncology
ALK